Socrus Pharmaceuticals Limited

Socrus Pharmaceuticals Limited - pharma in Dhar, Madhya Pradesh, India. FY 2026 financials and compliance.
CIN U24232MP1986PLC003300 Incorporated 13 February 1986 ROC Gwalior HQ Dhar, Madhya Pradesh, India
Active Public Limited Company pharma
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
*****
In full report
Net profit · Latest
*****
In full report
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹8.18 Cr
Issued & subscribed
Open charges
₹17.33 Cr
Satisfied ₹76.48 Lakh
Company age
40 yrs
Est. 1986
Last financials
Mar 2012
Balance sheet date

About Socrus Pharmaceuticals Limited

Data last updated: 07 February 2026

Socrus Pharmaceuticals Limited is a public limited company based in Dhar, Madhya Pradesh, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 13 February 1986, the company has been in operation for over 40 years.

Registered with ROC Gwalior under CIN U24232MP1986PLC003300.

Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹8.18 Cr. It is led by directors including Rajshree Trivedi and Madhvi Agnihotri.

Last AGM: 29 September 2012. Financial statements filed for year ended 31 March 2012. Office: Plot No – 252 Sector – I Pithampur, Dhar, Madhya Pradesh, India – 454775.

As per MCA filings, the company has open charges of ₹17.33 Cr and satisfied charges of ₹76.48 Lakh on record.

The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website socrus.com.

Company Details of Socrus Pharmaceuticals Limited
CIN U24232MP1986PLC003300
Registration Number 003300
Incorporation Date 13 February 1986
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2012
Date of Balance Sheet 31 March 2012
Compliance Status Active Non-Compliant
Key People
Rajeev Agnihotri Managing Director Rajshree Trivedi Director Madhvi Agnihotri Director
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Plot No – 252 Sector – I Pithampur, Dhar, Madhya Pradesh, India – 454775
  • Industry
    Pharma, Drug Formulation & Development
Company report
Socrus Pharmaceuticals Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Socrus Pharmaceuticals Limited report

Financials, compliance, directors, charges, ownership and filings for Socrus Pharmaceuticals Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Socrus Pharmaceuticals Limited

Socrus Pharmaceuticals Limited has one previous CIN (Corporate Identification Number): L24232MP1986PLC003300. The current CIN is U24232MP1986PLC003300, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24232MP1986PLC003300 Current
L24232MP1986PLC003300 Previous

Board of Directors of Socrus Pharmaceuticals Limited

Socrus Pharmaceuticals Limited is currently managed by 4 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Rajshree Trivedi Director 05 Jun 1990 36 Years 1 Months Current
Madhvi Agnihotri
Also directs: Socrus Bio Sciences Limited
Director 10 Jun 1995 31 Years 0 Months Current
Rajeev Agnihotri
Also directs: Socrus Bio Sciences Limited, Hshpt Drones Private Limited, Fast Track Hshpt Private Limited
Managing Director 27 Jan 1996 30 Years 5 Months Current
Sanjay Kumar Upadhyay
Also directs: Socrus Bio Sciences Limited
Additional Director 30 Jan 2012 14 Years 5 Months Current
View all directors

Financials of Socrus Pharmaceuticals Limited FY 2012 filings available

Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Socrus Pharmaceuticals Limited

Open charges
₹17.33 Cr
Satisfied charges
₹76.48 Lakh
Breakdown by lending institutions
Asset Reconstruction Company (India) Limited₹11.22 Cr
Panjab National Bank₹5.75 Cr
The Madhya Pradesh Financial Corporation₹0.35 Cr
Centurion Bank Ltd.₹0.01 Cr
Latest charge details
DateLenderAmountStatus
22 Aug 2006 Panjab National Bank ₹5.75 Cr Open
27 Dec 2004 Asset Reconstruction Company (India) Limited ₹15 Lakh Open
22 Nov 2004 Asset Reconstruction Company (India) Limited ₹10.25 Cr Open
13 Aug 2004 Centurion Bank Ltd. ₹1.05 Lakh Open
26 Jun 2004 Asset Reconstruction Company (India) Limited ₹3.88 Lakh Open

Total charge records: 14 View all charges

Employees and EPFO Compliance at Socrus Pharmaceuticals Limited

View historical data on people associated with Socrus Pharmaceuticals Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Socrus Pharmaceuticals Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Socrus Pharmaceuticals Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Socrus Pharmaceuticals Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Socrus Pharmaceuticals Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Socrus Pharmaceuticals Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Socrus Pharmaceuticals Limited

MSME Payment Delays by Socrus Pharmaceuticals Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Socrus Pharmaceuticals Limited

Subsidiaries & Group Companies of Socrus Pharmaceuticals Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Socrus Pharmaceuticals Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Socrus Pharmaceuticals Limited

MCA Filings & Documents of Socrus Pharmaceuticals Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Socrus Pharmaceuticals Limited

Charges
16 Oct 2014
A charge with Asset Reconstruction Company (India) Limited of Rs. 0.15 Cr registered on 27 Dec 2004 with Charge ID 90209799 was modified on 16 Oct 2014.
Charges
16 Oct 2014
A charge with Asset Reconstruction Company (India) Limited of Rs. 10.25 Cr registered on 22 Nov 2004 with Charge ID 90206231 was modified on 16 Oct 2014.
Charges
16 Oct 2014
A charge with Asset Reconstruction Company (India) Limited of Rs. 0.04 Cr registered on 26 Jun 2004 with Charge ID 90209614 was modified on 16 Oct 2014.
Charges
16 Oct 2014
A charge with Asset Reconstruction Company (India) Limited of Rs. 0.10 Cr registered on 18 Aug 1998 with Charge ID 90205379 was modified on 16 Oct 2014.
Charges
16 Oct 2014
A charge with Asset Reconstruction Company (India) Limited of Rs. 0.08 Cr registered on 18 Aug 1998 with Charge ID 90210166 was modified on 16 Oct 2014.
Charges
16 Oct 2014
A charge with Asset Reconstruction Company (India) Limited of Rs. 0.35 Cr registered on 27 Dec 1994 with Charge ID 90204990 was modified on 16 Oct 2014.

Frequently Asked Questions about Socrus Pharmaceuticals Limited

Socrus Pharmaceuticals Limited is an active public limited company in the pharma sector based in Dhar, Madhya Pradesh, India. It was incorporated on 13 February 1986 (40+ years old) and is registered under CIN U24232MP1986PLC003300.

The current directors of Socrus Pharmaceuticals Limited are:

The primary industry of Socrus Pharmaceuticals Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Socrus Pharmaceuticals Limited can be reached at the registered office: Plot No – 252 Sector – I Pithampur, Dhar, Madhya Pradesh, India – 454775, or through the website socrus.com.

The authorised capital is ₹10 Cr, and the paid-up capital is ₹8.18 Cr.

The company has its registered office at Plot No – 252 Sector – I Pithampur, Dhar, Madhya Pradesh, India – 454775.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available